These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19132538)

  • 1. Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
    Kuruba R; Wilson A; Gao X; Li S
    AAPS J; 2009 Mar; 11(1):23-30. PubMed ID: 19132538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
    de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
    Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review.
    Geinguenaud F; Guenin E; Lalatonne Y; Motte L
    ACS Chem Biol; 2016 May; 11(5):1180-91. PubMed ID: 26950048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
    Ogris M; Wagner E
    Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery systems for oligonucleotide therapeutics.
    Yu B; Zhao X; Lee LJ; Lee RJ
    AAPS J; 2009 Mar; 11(1):195-203. PubMed ID: 19296227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids.
    Nimesh S; Gupta N; Chandra R
    J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles as vehicles for macromolecules: nucleic acids and peptides.
    del Pozo-Rodríguez A; Delgado D; Solinís MA; Gascón AR
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):214-26. PubMed ID: 21834776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in nanoparticulate systems for peptide, proteins and nucleic acid drug delivery.
    Slomkowski S; Gosecki M
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1823-39. PubMed ID: 21902630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
    Fattal E; De Rosa G; Bochot A
    Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized Medications for Gene and Peptide Therapy.
    Laube BL
    Respir Care; 2015 Jun; 60(6):806-21; discussion 821-4. PubMed ID: 26070576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
    Vaughan HJ; Green JJ; Tzeng SY
    Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of therapeutic oligonucleotides to pulmonary circulation.
    Wilson A; He F; Li J; Ma Z; Pitt B; Li S
    Adv Genet; 2005; 54():21-41. PubMed ID: 16096006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
    Kriegel C; Attarwala H; Amiji M
    Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.
    Fattal E; Fay F
    Adv Drug Deliv Rev; 2021 Aug; 175():113809. PubMed ID: 34033819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptides for the delivery of nucleic acids.
    Lehto T; Kurrikoff K; Langel Ü
    Expert Opin Drug Deliv; 2012 Jul; 9(7):823-36. PubMed ID: 22594635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.